Home > News > Company News > Schott inaugurates new Indian glass tank facility following €21 million investment

Schott inaugurates new Indian glass tank facility following €21 million investment

Post Time:Dec 12,2019Classify:Company NewsView:1346

Schott has inaugurated its new glass tank facility in Jambusar, Gujarat, India following an investment of €21 million last year.


The company has also committed additional investments of €26 million for another tank facility in 2020.


Each of the new production facilities will double the capacity of Schott Glass India’s manufacturing plant, allowing the group to produce its highly specialised FIOLAX tubing material for both domestic and export demands.


Schott began the construction of its first new facility last year on the occasion of completing two decades of operations in India.


The facility finished construction within a record time of one year, enabling employment of another 100 skilled local workforce.


Talking about Schott Glass India’s future plans, Managing Director, Georg Sparschuh said: “While domestic market remains our key focus, our India plant also caters to the Asian market, thereby contributing to pharmaceutical industry exports and the Indian government’s vision of becoming a global pharmaceutical hub.


Schott also understand the Indian Health Ministry’s initiative to provide affordable and accessible healthcare to its citizens.


It aims to contribute to the pharmaceutical value chains and by providing high-quality glass products for pharma packaging, ensuring highest global safety standards.


Dignitaries from the German Embassy- Mumbai in India, and Marja Einig, Deputy German Counsel also attended the inauguration of the new facility.


On the occasion, Ms Einig commended the efforts and said: “Schott is playing a pivotal role in giving a fillip to our efforts in strengthening the Indo-German partnership.


“Time and again, Schott has showcased its commitment towards India.


“With its expanded operations in the country, it is catering to the needs of the Indian health industry and contributing to the Indian government’s initiatives such as Make in India and Pharma Vision 2020.”

Source: Schott AGAuthor: shangyi

Hot News

返回顶部